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The  demonstration that pneumococcal polysaccharides (1-6)  and purified 
blood group substances (of. reference 7) are antigenic in some species and not 
in  others  and  the more  recent  finding  that  dextrans  are  antigenic  in  man 
(8-10) but not in the rabbit (11,  12)  or guinea pig (12)  prompted an investi- 
gation of the antigenicity of several other purified polysaccharides in human 
beings.  Levan, apple  amylopectin, maize glycogen, and two synthetic poly- 
glucoses were tested for their ability to stimulate production of specific  anti- 
body. In a  small series of individuals injected with these materials, antibody 
formation as evidenced by the appearance of precipitins and wheal and ery- 
thema type skin sensitivity was obtained only against levan. 
While levan has never been reported to be antigenic in man, Horsfall (13) 
and  Genghof (14)  noted that purified levan preparations are  not antigenic 
when injected intravenously into  rabbits  in  amounts from 0.15  to  15  rag. 
Rabbit  antisera  to  levan,  however,  have  been  obtained  by  immunization 
with  heated  or  formol-treated  suspensions  of  Streptococcus  salivarius  and 
Bacillus N-9 grown in sucrose-containing media but not with these organisms 
grown on glucose (15).  These rabbit antisera have been shown to give com- 
plement  fixation and  precipitation  with  a  number  of  levans isolated  from 
supernates of bacterial cultures grown on sucrose or raffinose as well as with 
levans synthesized by cell-free enzyme preparations  (16,  17).  Living suspen- 
sions of Aerobacter  levanicum  grown on sucrose have also been employed to 
immunize rabbits  and  the  antisera  produced  used  in  qualitative  precipitin 
tests.  Oligolevans  were  found  to  inhibit  the  levan-antilevan  precipitation 
(18). 
In this investigation antiserum from an individual who showed the greatest 
antibody response to levan was studied by the micro-quantitative precipitin 
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method  of  Heidelberger  and  MacPherson  (19)  using  a  variety  of  levans. 
Immunochemical  evidence  for  the  existence  of  structural  differences among 
levans was obtained. 
Analysis of specific precipitates for  distinctive constituents  of the antigen 
has  been  employed to  estimate degree of purity of antigens and  to  provide 
evidence that a  given antibody combines with and specifically precipitates a 
given  antigen  (cf.  reference  7  for  review).  Distinctive  constituents  of  anti- 
gens  such  as  iodine  (20),  copper  (21),  hexosamine  (22-24),  methylpentose 
(25,  26), radioactivity (9), galactose and uronic acid (27)  and hydroxyproline 
(28)  have  been  employed  in  the  analysis  of  specific precipitates.  Antibody 
involved in  the  present  study  can  be  shown  to  be  antilevan by its  specific 
capacity to precipitate levan as demonstrated by the presence of fructose in 
the specific precipitate. 
A  non-specific anamnestic rise in antidextran or anti-A precipitins resulting 
from  levan immunization  was  not  found.  In  addition,  purified soluble lami- 
narin,  a  neutral polysaccharide obtained from Laminaria digitata,  was found 
to give precipitation with normal human sera. 
Materials and Methods 
Four levans, designated by the number  of the causative strain, were  supplied  by the 
Northern Utilization Research Branch,  United States Department of Agriculture, Peoria, 
Illinois, through the courtesy of Dr. Allene Jeanes,  as follows: NRRL P-6  (3727-10), the 
product of an unidentified  microorganism;  and NRI~ B-523 (3564-45 fraction M), NRRL 
B-512-E (3525-77) and NRRL B-512 (P.P.2,  3801-30 fraction B)which were by-products of 
dextran production by strains of Leuconostoc mescn~roides (42).  Levan  P-6 contains 94.5 
per cent polymerized fructose with a nitrogen content of 0.05 per cent, while the other three 
samples each contain 96 per cent combined fructose (29). 
A native levan prepared from culture filtrates of Aerobacter levanicum grown on sucrose 
(30 a), and purified by repeated methanol precipitation, was kindly supplied by Dr. Shlomo 
I-Iestrin of the Hebrew University, Jerusalem; it had a  molecular weight of 50 X  106 (deter- 
mined by light scattering), a nitrogen content of 0.1 per cent and is a branched molecule 
made up mainly of 2,6' linkages with about 10 per cent 1,2' linkages (30 b). Levan fractions 
A and B were prepared in Dr. Hestrin's laboratory by methanol precipitation of a partial acid 
hydrolysate (acetate, pH 3.4 at 50* for 1 hour) of the native levan from Aerobac~er  levanicum. 
Fraction A was precipitated at 55 per cent methanol by volume, while fraction B was ob- 
tained between 55 and 53 per cent. Fractions A and B show different degrees of polymerization 
in that the ratios of reducing ability after hydrolysis to those before hydrolysis were 610 and 
254 respectively (30 b).  Perennial rye grass levan (32) was obtained from Dr. E. L. Hirst. 
Samples of maize glycogen, apple amylopectin, and soluble laminarin were  supplied by 
Dr. W. Z. Hassid. Polyglucose 2947-53 was obtained from Drs. Zambito and Denkewalter of 
Merck and Company,  Inc., while polyglucose P-218-56 was obtained from Dr. P. T. Mora 
of E. I. Dupont de Nemours and Company. 
Skin Testing and Immunization  Procedures.--Polysaecharides used for immunization and 
skin testing were made up in saline, containing 0.25 per cent phenol, to a concentration of 1 
nag. per ml. Volunteers were initially bled, skin-tested, and then each received subcutaneous 
injections of 0.5 ml.  (0.5 rag.)  antigen on each  of 2 successive days.  Intracutaneous skin 
tests were carried out by injecting about 0.02 ml. antigen solution along with a control con- P.  Z.  ALIEN  AND  E.  A.  KABAT  385 
sisting of phenolized saline solution. Both sites were examined after 15 minutes, at which 
time the size of wheal and erythema reactions was recorded. Cutaneous reactions were com- 
pared in size with those elicited at the control site and were graded  from  --  to ++++. 
3 weeks after the last injection, a  postimmunization bleeding was taken and subjects were 
retested for skin sensitivity. 
Quantitative Precipitin Sludies.--Procedures used in preliminary testing of pre- and post- 
immunization sera for antibody N  were those described in detail for antidextran (8 b), using 
3  ml.  of serum  and  10 and  25 #g.  of antigen. Postimmunization bleedings were  obtained 
from a subject (No. 1) who had shown the greatest antibody response and were used in quan- 
titative precipitation studies.  Subject  1 had previously been immunized with dextran and 
purified blood group substances (hog A, horse A  and B).  Anti-levan serum  1  DnL~  t  was 
absorbed with dextran and hog A  substance and the absorbed serum employed in the pre- 
cipitin reaction. Precipitin curves with absorbed antiserum 1 DuL2 were obtained by the quan- 
titative precipitin method of Heidelberger and MacPherson  (19)  employing  1.0 ml.  serum 
which was added to analytically measured amounts of polysaccharide. The total volume was 
2.0 ml.  Washed specific precipitates were analyzed for antibody N  by the Folin-Ciocalteu 
tyrosine method (of. reference 33), employing reagents standardized against known amounts 
of normal human gamma globulin (34)  and antibody (35). 
Ketosugar  Estimations  on  Specific  Precipitates.--Based  on  the  quantitative  precipitin 
curves, washed specific  precipitates obtained in the region of antibody excess were analyzed 
for ketosugar by the cysteine-carbazole method of Dische and Borenfreund (36). Precipitates 
were formed and washed in 15 m]. conical centrifuge tubes. After breaking up and suspending 
the washed precipitates in 1.0 ml. distilled H20, 0.2 ml. cysteine hydrochloride (0.15 per cent 
aqueous solution) was added followed by addition with constant shaking of the sulfuric acid 
reagent (6 ml. of a mixture of 190 nil. H20 and 450 ml. concentration H2S04 c.P.). 0.2 ml. of 
the carbazole reagent (0.12 per cent alcoholic solution) was added immediately, the mixture 
shaken and allowed to stand at room temperature for 24 hours. Reagent blanks, levan stand- 
ards, controls of normal gamma globulin, and gamma globulin plus levan were set up at the 
same time and included in each determination. Concentrations of gamma globulin N included 
in controls for each levan were comparable in N  to those contained in the various specific 
precipitates as determined from  the precipitin curves. Human gamma globulin was found 
not  to  interfere with  the color intensity or  development in  the concentrations employed 
(up to 25/~g N), thus corrections for color due to antibody were not needed. The violet color 
developed after 24 hours was read in the Beckman spectrophotometer as  the difference in 
optical densities at 5600 and 7500 A.  Concentrations of antigens  were chosen so that pre- 
cipitates did not contain more than 10 #g. levan. 
RESULTS 
Table  I  summarizes responses obtained on injection of human volunteers 
with various polysaccharides. A  rise of 2 #g.  or over, in precipitable N  per 
ml. serum is considered significant. This occurred in four individuals (Nos.  1, 
131, 144, 148) following subcutaneous injection of levan. Subject 1 showed a 
rise  in  N  specifically precipitable  by levan from 0.4  to  16.7 #g./ml.  while 
subjects 131, 144, and 148 went from 1.0 to 3.4 #g., 0.0 to 3.1 #g., and 0.9 to 
3.7 #g.N/ml., respectively. Six individuals injected with maize glycogen, five 
I Dlz signifies the llth bleeding following dextran immunization and L2, the 2nd bleeding 
70 days after immunization with levan. TABLE  I 
Response to Injection of Various Polysacckarides in Man 
Polysaccharide  Subject 
No. 
Maximum/Zg. N precipitable 
from 1.0 ml. serum  Cutaneous reaction 
Pre-  Post-  Prehnmunization  Postimmunization  immunization  immunization 
~g. 
16.7  + 
0.7  4- 
o.o  + 
3.4  + 
0.0  4- 
0.4 
1.0  4- 
0.0  4- 
0.I  4- 
0.8 
0.4  4- 
3.1 
0.1  + 
/~g. 
Levan P-6 (NRRL)  1  0.4 
129  0.2 
130  0.1 
131  1.0 
132  0.2 
133  0.0 
134  1.6 
140  0.I 
141  0.0 
142  1.1 
143  0.3 
144  0.0 
145  0.0 
Native levan Aero.  146  0.1 
batter l~anicum  147  O. 2 
148§  0.9 
Maize glycogen  121  0.4 
122  1.0 
123  0.4 
124  0.3 
125  0.3 
126  1.3 
8.pple amylopectin  135  0.7 
136  0.4 
137  0.6 
138  O. 2 
139  1.1 
Polyglucose  59  3.3  (0.2) ¶ 
2947-53  (Merck)  60  1.5  (0.0) 
61  1.5  (0.4) 
62  1.6  (0.0) 
63  2.3  (0.3) 
64  3.0  (o.o) 
77  1.2  (0.0) 
78  2.3  (0.2) 
79  2.4  (0.0) 
80  0.9  (0.1) 
8~  0.0  (0.0) 
82  0.3  (0.2) 
Polyglucose  71  0.2 
P218-56  72  0.0 
(DuPont)  73  0.2 
74  0.1 
75  0.1 
76  0.1 
+4- 
+ 
+ 
4- 
4- 
4- 
4- 
+4- 
4- 
+4- 
++ 
0.0 
0.0 
3.7 
0.7 
0.2 
0.4 
0.9 
0.2 
0.8 
0.8 
0.7 
1.0 
0.1 
0.1 
3.9 
2.0 
1.8 
1.5 
2.7 
2.4 
1.2 
3.2 
1.6 
0.3 
0.1 
1.2 
0.0 
0.1 
0.2 
0.2 
0.3 
0.1 
-*, ++++:~ 
-,  ++++~: 
-*  ++++ll 
I 
(0.0) 
(o.o) 
(o.o) 
(0.s) 
(o.s) 
(o.o) 
(0.3) 
(0.3) 
(o.o) 
(o.1) 
(o.I) 
(0.3) 
4-,  ++++$ 
++++* 
m 
++ 
4- 
-4- 
4- 
+ 
m 
1 
m 
m 
m 
D 
m 
m 
m 
B 
4- 
1 
* Reading after 15 minutes. 
~: After 6 hours. 
§ Subject received only single subcutaneous injection (0.5 mg.)  of antigen. 
II After 2~ hours. 
¶  Values in parentheses indicate #g.N/ml. precipitable by DuPont P  218-56 polyglucose. 
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with  apple  amylopectin,  twelve with  Merck  synthetic polyglucose 2947-53, 
and  six  with  Dupont  synthetic polyglucose P218-56  showed no  increase  in 
nitrogen precipitable by the homologous polysaccharides. 
Quantitative precipitin curves were obtained with various levans employing 
1.0 ml. of absorbed antilevan serum 1 DuL~. Antilevan levels measured before 
and after absorption with dextran  and blood group substance were 26.6 #g. 
~25 
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0  FrM  B523  A  HESTRIN  LEVAN A 
0  BSI2E  B  HESTRIN  LEVAN B 
•  B512PP2  Fr8  •  RYE  GRASS  LEVAN 
N  INULIN 
Fro.  1.  Precipitin reaction of levans with  1.0  ml.  antiserum  1 Du  I~  (dextra~ and A 
absorbed). 
and 23.6 #g.N/ml., respectively, as shown in Table II. In view of the multiple 
absorptions this is within experimental error. 
As can be seen from Fig.  1, six of the levan preparations tested were able 
to  precipitate  from  21.9  to  24.2  #g.  antibody N/ml.,  amounts  comparable 
within  experimental  error  to  the 23.6 #g.N precipitable  by the homologous 
levan  P-6.  Hestrin  levan  fraction  B,  precipitated  somewhat  less  antibody 
(18.8 #g.N/ml.) while rye grass precipitated only 6.3 #g. antibody N. Amounts 
of inulin  from  5  to  104 #g.  gave no  precipitation;  in  high  concentrations, 
however,  33.6  rag.  of inulin  precipitated  6.8  #g.  N.  Although  preparations 
B523 fraction M, B512 E, B512 P.P.2. fraction B, Hestrin native levan, and 388  POLYSACCHA/UDES AND ANTIBODY FORMATION 
Hestrin fraction A remove all antibody to levan P-6, as evidenced by failure 
of  supernates  at  the  point  of maximum precipitation  with  these  levans  to 
give further precipitation on addition of levan P-6,  they differ in  their ca- 
pacity to precipitate antibody per unit weight just as has been found with 
dextran (8, 37).  Thus levan P-6, Hestrin native and fraction A levans require 
only 3 #g. fructosan to precipitate 50 per cent of the maximum antibody N, 
while preparations B523 fraction M, B512 P.P.2 fraction B, and B512 E  re- 
quire 5, 20 and 34 #g. levan, respectively. 
As shown in Table II, levels of antibody N  preclpitable by levan showed a 
rise from 0.4 to 16.7 #g. antibody N/ml. within 3 weeks following levan injec- 
tions, while antidextran and anti-A precipitin levels remained essentially un- 
TABLE n 
Circulating  Precipitin  Levds in Subject 1 before and after  Levan Injection 
Levan P-6 
Dextran native NRRL B1255~ 
Hog 30§ 
Maximum #g. antibody N/ml. precipitated 
Beforelevan 
injection 
DgLx bleeding 
(Jan. 28, 1954) 
0.4 
17.1 
21.6 
Afte  levan  injection 
DloL1 bleeding 
(Feb. 17, 1954) 
16.7 
17.1 
21.3 
DnL~ bleeding (Apr. 8, 1954) 
Unabsorbed  Absorbed* 
26.6  23.6 
16.4 
20.9 
* Serum absorbed with dextran B1255 and purified blood group substance (hog A prep- 
aration). 
~: See reference  8 b. 
§ Purified blood group A substance, see Leskowitz, S., and Kabat, E. A., Y. Am. Chem. 
Soc., 1954, 76, 4887; Kabat, E. A., and Leskowitz,  S., Y. Am. Chem. Soc., 1955, 77, 5159. 
changed. Bleeding DnI~ taken 70 days following initial immunization showed 
an increase in antilevan over the 20 day sample attaining a peak of 26.6 pg. 
antibody N/ml.  Despite  this  further  increase,  antidextran  and  anti-A  re- 
mained  unchanged  from  prelevan  immunization values.  Subsequent  deter- 
minations after immunization showed gradual declines in all three antibodies 
comparable  to  those observed  with pneumococcal anticarbohydrate  (38). 
Antiserum 1 DilL2 can be shown to be antilevan by its specific  capacity to 
precipitate  levan  as  evidenced  by  the  presence  of  ketosugar  (fructose)  in 
specific  precipitates.  Table  III  shows ketosugar  determinations on  washed 
specific  precipitates  determined by  the  cysteine-carbazole method.  Precipi- 
tates  formed in  the  region  of  antibody excess  employing 5  #g.  levan P-6, 
B523  fraction M,  and  Hestrin native  and  fraction A  levans  show  86-100 
per cent of the levan added as antigen to be recoverable in the washed pre- 
cipitates. In the equivalence zone or at the point of maximum precipitation P.  Z.  ALLEN  AND  E.  A.  KABAT  389 
74--94 per cent recovery was obtained. Analysis of precipitates formed at the 
point of maximum precipitation with 5 #g.  Hestrin levan fraction B  and rye 
grass levan show low levan recoveries. 
Subject  144,  injected  with levan P-6,  showed increased skin reactivity ac- 
companying a small increase in precipitins, while subjects 1 and 131 who were 
initially reactive, showed little or no increase in cutaneous sensitivity despite 
a  rise in precipitins.  Two subjects  (141  and  145)  showed a  slight increase in 
skin  reactivity  without  production  of  circulating  precipitin,  nor  was  non- 
TABLE III 
Ketosugar Estimations on Specific Precipitates 
Amount levan  Antibody N  Levan recovered  in specific  Recovery  Levan preparations  added  precipitated  precipitate 
Levan P-6 
B523 fr. M 
Hestrln native 
Hestrin fraction A 
Hestrin fraction B 
Rye grass 
/Zg. 
5.0 
10.0 
5.2 
10.4 
5.0 
10.0" 
5.0 
10.0 
5.0 
10.0 
5.0 
10.0 
/.Lg. 
18.6 
22.3 
12.2 
18.2 
21.9 
21.8 
17.5 
21.9 
18.8 
18.3 
6.3 
5.6 
Pg. 
4.4 
8.6 
4.6 
9.8 
5.0 
8..5 
4.3 
7.4 
3.2 
5.7 
0.3 
1.2 
p~¢eng 
88 
86 
88 
94 
100 
88 
86 
74 
64 
57 
6 
12 
* Average of analyses run in triplicate, all other analyses in duplicate. 
precipitating  (coprecipitating)  antibody  found  when  these  sera  were  tested 
for their ability to add N  to a specific levan-antilevan precipitate. Preliminary 
sensitivity to levan P-6 was shown by four subjects  (1,  130,  131,  145)  prior 
to  injection;  two  of  these  (130,  145)  failed  to  produce  antibody.  The  best 
response to levan was obtained in an individual  (No.  1)  who had shown  an 
excellent  capacity  to  produce  antibodies  to  dextran  and  blood  group  sub- 
stances. 
Initial skin testing of three individuals with the A erobacter levanicum sample 
of native levan showed this preparation to have some degree of toxicity and 
it  elicited intense  local reactions  which  appeared after 2~/~ to 6  hours.  Tox- 
icity is associated with individual batches containing trace contaminants and 390  POLYSACCHARIDES AND  ANTIBODY  ~OP,  MATION 
Hestrin's data indicate that it is not associated with the levan itself (31) but 
is  probably  due  to  some  contaminant.  One  subject  (No.  148)  showed such 
severe local reaction including marked edema about the site following a single 
subcutaneous injection that immunization  with this preparation  was immedi- 
ately discontinued.  This single injection resulted in the appearance  of signifi- 
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FIG.  2. Plot  of  N precipltatcd  from 1.0  ml. various  human sera  by soluble  laminarin. - 
normal human sera,  -.- antiserum ID8 (abs.);  - - antiserum I  DuLg_ (abs.).  Antisera  ab- 
sorbed  with  dextran  and blood  group  A substance. 
cant amounts of antibody N. Intradermal injection  of this  preparation elicited 
a local reaction in the rabbit, induration and erythema  appeared  with{n  1 
hour and reached maximum  intensity at about 6 hours,  while comparable 
amounts of fractions A  and B  showed little  or no reaction over saline control 
sites. The other levans caused no significant  reactions. 
Purified soluble laminarin was found to give precipitation with absorbed 
anti-levan serum 1 DnLs. Study of preimmunization sera taken from five  nor- 
mal subjects and from individual 1 before and after levan injection (I Ds and 
1 DIjL2) also  showed ability to form precipitates with laminarin. These pre- P.  Z.  ALLEN  AND  E,  A.  KABAT  391 
dpitates  are  unlike  carbohydrate-anticarbohydrate  specific  precipitates  in 
appearance in that they are very finely divided and do not form a  pellet on 
centrifugation, but pack as a  fine sediment. While the nature of this precipi- 
tate has not been studied, it produces a  blue color with the Folin-Ciocalteu 
phenol reagent.  Fig. 2 shows a plot of N  precipitated from 1.0 ml. serum by 
increasing  amounts of laminarin,  determined arbitrarily as g, mma globulin N. 
The extent of precipitation by any given quantity of laminarin,  as shown 
by Fig.  2,  varies considerably for each individual  serum tested. Addition of 
104  /~g. laminarin  precipitated  only  1.6  tzg.N/ml,  from  the  least  reactive 
serum (No. 164), while 10.4 ~g.N/ml. was precipitated from the most highly 
reactive serum (No. 1). While immunization with levan caused a rise in anti- 
body N so that absorbed antiserum 1 DnL~ contained 23.6 ~g. antibody N/ml., 
comparison with an earlier preimmunization  serum sample  (1 Ds absorbed) 
showed no increase in N  precipitable by laminarin. 
Sera  tested with Merck polyglucose 2947-53 show  small  amounts  of  pre- 
cipitable  N  both  before and  after  immunization  (Table  I),  while  DuPont 
polyglucose P218-56 fails to precipitate. While values in Table I are reported 
per milliliter  serum,  the precipitin  tests were actually performed with 3 ml. 
of serum and  showed definite disc-like  precipitates with  the Merck  sample, 
while  no  evidence of precipitation  was seen with DuPont polyglucose. This 
difference  in  ability among polyglucose samples to precipitate  N  from both 
pre- and postimmunization sera is especially evident when both polyglucoses 
are tested with  the same serum.  Sera  (59-54 and  77-82)  which show small 
amounts of N  precipitable by Merck polyglucose show little or no precipitate 
N  (Table I, values in parentheses)  when tested with the DuPont sample. 
DISCUSSION 
The data show that purified levans are antigenic in man,  in that subcuta- 
neous injection of 1 rag.  of levan can give rise to the production of antibody 
specifically precipitable by levan. In a small number of individuals no evidence 
of antibody production was obtained after injection of comparable amounts 
of apple amylopectin, maize glycogen,  and synthetic polyglucose. 
]mmunochemical findings  that levan preparations B523,  fraction M, B512 
P.P.2 fraction B, and B512E show differences  per unit weight in their ability 
in  precipitating  antibody  are  best  interpreted  as  indicating  structural  dif- 
ferences among these preparations analogous to similar  findings with dextrans 
(37).  While structural information on these materials is fragmentary,  inhibi- 
tion studies undertaken in collaboration with Dr.  Shlomo Hestrin employing 
oligosaccharides  of known structure show the anti]evan to have a  specificity 
involving fructo-furanose units in 2,6  t linkage.  This can also be inferred from 
Fig.  1, from which it can be seen that while rye grass levan and inulin have 
comparable molecular weights  (about 5000),  inulin,  in which fructofuranose 392  POLYSACCHARIDES  AND  ANTIBODY  ]~ORMATION 
residues occur in  1,2'  linkage,  fails to precipitate  anti-levan while  rye grass 
levan, made up of 2,6'  linkages  (32),  is able to precipitate about J~ of the 
anti-levan. 
Inhibition of precipitation of anti-levan by levan P-6 is not observed with 
inulin.  Addition  of 25 #g.  homologous levan to  supernates  of points set up 
with  10.0, 20.4,  and 33.6 rag.  inulin  shows that  of the 23.6 #g.  antibody N 
originally  present,  22.6,  22.8,  and  22.2 #g.  N  respectively could be precipi- 
tated. The small amount of precipitate formed at high inulin concentrations 
is not due to antilevan since addition of 33.6 mg. inulin to serum completely 
absorbed of its anti-levan  precipitated  6.8/zg.  N  from  the absorbed serum. 
That antibody formed is levan-specific and not antibody to trace contaminants 
is shown by the capacity of absorbed antiserum 1 DnL2 specifically to precipi- 
tate levan as evidenced by the high recoveries (86--100 per cent)  in  specific 
precipitates of levan added as antigen. 
Although  no evidence was obtained of antibody formation resulting  from 
injection  of  synthetic  polyglucoses,  differences  among  polyglucose samples 
were found. Absence of precipitation  by DuPont polyglucose P-218-56  is in 
agreement with the finding  (8 b) that Merck polyglucose 2947-53 shows cross 
reaction with antidextran  sera,  while  the former does not. Moreover, Heidel- 
berger and Aisenberg  (39), have shown that polyglucose P-218-56 differs from 
other  synthetic polyglucoses in  that  it  shows considerably lower cross-reac- 
tivity  in  horse  antipneumococcus  sera.  Structural  differences  among  these 
polyglucoses  which  could  account  for  differences  in  cross-reactivity  with 
antidextran may also allow the Merck sample to cross-react with small amounts 
of some antibody present in normal  sera.  Immunization  with levan failed to 
induce a  non-specific  anamnestic rise  in antibody N  precipitable by dextran 
or purified  blood group A  substance. 
Precipitation of N  from normal sera has been observed with several carbo- 
hydrates.  Glycogen in large  amounts is able to form precipitates with normal 
sera of several species (40) while normal human serum forms precipitates with 
higher  concentrations  of  cycloheptaamylose but not  cyclooctaamylose (41). 
The observation that soluble laminarin,  a neutral polysaccharide, is able to 
precipitate N  from normal human sera remains to be explained. 
SUMMARY 
Purified  levan  is  antigenic  in  man  and  subcutaneous injection  of  1 rag. 
leads to the production of precipitins and skin sensitivity. Apple amylopectin, 
maize  glycogen,  and  synthetic polyglucose did not  stimulate  antibody pro- 
duction in  small  numbers of individuals  injected. 
Quantitative precipitin  studies carried out with several levan preparations 
employing  human  antilevan  show  variations  in  immunochemical  behavior 
indicating  structural  differences  among levans. P.  Z. ALLEN AND E.  A.  KABAT  393 
Evidence that precipitins formed in  response  to  levan injection are  anti- 
levan  antibodies was obtained by analysis of specific  precipitates formed in 
the region of antibody excess for ketosugar. 
Injection of levan giving rise to production of antilevan failed in one indi- 
vidual to give a non-specific anamnestic rise in either antidextran or antiblood 
group A precipitins. 
Laminarin, a  neutral polysaccharide, was found to give precipitation with 
normal human sera. 
BIBLIOGRAPHY 
1.  Schiemann, O. and Casper, W., Z. Hyg. u. infektionskrankh,  1927, 108, 220. 
2.  Francis,  T., Jr., and Tillett, W. S., J. Exp. Med.,  1930, 52, 573. 
3.  Francis,  T., Jr., Proe. Soc. Exp. Biol. and Med.,  1934, 31, 493. 
4.  Felton, L. D., Sufliff, W. D., and Steele, B. F., J. Infea. Dis.,  1935, 56,  101. 
5.  Heidelberger,  M., MacLeod,  C. M., Kaiser,  S. J., and Robinson,  B., J. Exp. 
Med., 1946, 88, 303. 
6.  White, B., The Biology of the Pneumococcus, New York, The Commonwealth 
Fund,  1938. 
7.  Kabat, E. A., Blood Group Substances, New York, Academic Press, Inc., 1956. 
8.  Kabat, E. A., and Berg, D., (a) Ann. New York Acad. Sc.,  1952, 55, 471; (b) 
J. Immunol.,  1953, 70, 514. 
9.  Kabat, E. A., Berg, D., Rittenberg, D., Pontecorvo,  L., Eidinoff, M. L., and 
Hellman,  L., J. Am. Chem. Soc., 1954, 76, 564. 
10.  Maurer, P. H., Proc. Soc. Exp. Biol. and Med.,  1953, 83, 879. 
11.  GrSnwall, A., and Ingehnan, B.,  Acta Physiol. Stand.,  1944, 7, 97. 
12. Bull, J. P., Ricketts, C.,  Squire, J. R., Maycock, W. D'a., Spooner, S. J. L., 
Mollison, P. L., and Patterson, J.  C. S., lancet,  1949, 256,  134. 
13. Horsfall,  F. L., Jr., J. Exp. Med.,  1951, 93, 229. 
14.  Genghof, D. S., thesis, New York,  Cornell University,  1945. 
15. Hehre, E. J., Genghof, D. S., and NeiU, J. M., J. Immunol.,  1945, 51, 5. 
15. Hehre, E. J., (a) Proc. Soc. Exp.  Biol.  and  Med.,  1945, 58,  219; (b)  Tr.  New 
York  Acad. Sc.,  1948, 10,  188. (c) J. Exp. Med.,  1946, 83, 147. 
17.  Genghof, D. S., Hehre, E. J., and NeiU, J. M., Proc. Soc. Exp. Biol. and Med., 
1946, 61, 339. 
18.  Schramm,  M.,  M.  Sc.  thesis,  The  Hebrew  University,  Jerusalem,  Hadassah 
Medical  College, 1951. 
19. Heidelberger, M. and MacPherson,  C. F. C., (a)  Science, 1943, 97, 405; (b)  98, 
63. 
20.  Stokinger, H. E., and Heidelberger, M., J. Exp. Med.,  1937, 66, 251. 
21. Hooker,  S. B., and Boyd, W. C., Ann. New York Acad. Sd.,  1942, 43,  107. 
22. Bendich, A., Kabat, E. A., and Beze  L A. E., J. Exp. Med.,  1946, 83, 485. 
23. Kabat, E. A., Baer, H., Day, R. L., and Knaub, V., J. Exp. Med.,  1950, 91, 
433. 
24. Johns, R. G. S., and Marrack, J. R., J. Hyg.,  1953, 51, 55. 
25.  Kabat, E. A., Baer,  H., and Knaub, V., J. Exp. Med.,  1949, 89,  1. 394  POLYSACCHARIDES  AND ANTIBODY ~0RMATION 
26. Beiser, S. M., Kabat, E. A., and Schor, J. M., a  r. Imraunol.,  1952, 69, 297. 
27. Heidelberger,  M., Dische, Z., Brock Neely, W., and Wolfrom, M. L., Y. An,. 
Chem. Soc.,  1955, 77,  3511. 
28. Maurer, P. H., and Lebovitz, H., J. Immunol., 1956, 76, 335. 
29. Jeanes, A., personal communication. 
30.  (a) Hestrin, S.,  Avineri-Shapiro,  S., and Aschner, M., Biochem. J.,  1943, $7~ 
450. (b), personal communication. 
31. Davies,  A. M., Shilo, M., and Hestrin, S., Brit. Y. Exp. Path.,  1955, 36, 500. 
32. Laidlaw,  R. A., and Reid, S.  G., J. Chem. Sot.,  1951, 1830. 
33. Kabat,  E.  A.,  and Mayer, M.  M.,  Experimental  Immunoehemistry, Spring- 
field, Illinois,  C. C Thomas, 1948. 
34. Kabat, E. A., and Bezer, A. E., Y. Exp. Meal., 1945, 82, 207. 
35. Beiser, S. M., and Kabat, E. A., Y. Am. Chem. Sot., 1951, 739 501. 
36. Disc.he, Z., and Borenfreund,  E., J. Biol.  Chem., 1951, 193, 583. 
37.  AUen, P. Z., and Kabat, E. A., Y. Am. Chem. Sot., 1956, 78,  1890. 
38. Heidelberger,  M.,  in  The  nature and  significance of  the  antibody response, 
New  York Acad.  Med. Syrup.  No.  5,  1953, 90. 
39. Heidelberger, M., and Aisenberg, A. C., Proc. Nat. Acad. Sc.,  1953, 39, 453. 
40.  Grabar,  P., Ann. Inst. Pasteur,  1955, 88,  11. 
41. Kabat, E. A., Y. Am. Chem. Soc.,  1954, 76, 3709. 
42. Wilham, C. A., Alexander, B. H., and Jeanes, A., Arch. Biochem. and Biopkysi¢., 
1955, 59, 61. 